JNK Antikörper (AA 145-419)
Kurzübersicht für JNK Antikörper (AA 145-419) (ABIN7613096)
Target
Alle JNK (MAPK8) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 145-419
-
Verwendungszweck
- c-Jun N-terminal Kinase 1 (JNK1) Polyclonal Antibody
-
Sequenz
- Ala145~Ala419
-
Produktmerkmale
- The c-Jun N-terminal Kinase 1 (JNK1) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, IF.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.37 mg/mL
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- JNK (MAPK8) (Mitogen-Activated Protein Kinase 8 (MAPK8))
-
Andere Bezeichnung
- JNK1
-
Gen-ID
- 5599
-
UniProt
- P45983
-
Pathways
- MAPK Signalweg, WNT Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Hepatitis C, Toll-Like Receptors Cascades, Signaling of Hepatocyte Growth Factor Receptor, S100 Proteine
Target
-